WEST PHARM.SVCS DL-,25WW

WEST PHARM.SVCS DL-,25

198.70EURD
+4.75+2.45%
At close at Feb 21, 22:08 GMT
EUR
No trades
See on Supercharts
Next report date
April 24
Report period
Q1 2025
EPS estimate
1.17 EUR
Revenue estimate
‪652.65 M‬ EUR
Market capitalization
‪14.52 B‬EUR
6.50EUR
‪475.94 M‬EUR
‪2.79 B‬EUR
‪71.88 M‬
Beta (1Y)
0.27
Employees (FY)
‪10.6 K‬
Change (1Y)
0
Revenue / Employee (1Y)
Net income / Employee (1Y)

About West Pharmaceutical Services, Inc.


CEO
Eric Mark Green
Headquarters
Exton
Founded
1923
FIGI
BBG000JL73P1
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Performance
‪15%‬
‪16%‬
‪17%‬
‪18%‬
‪19%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Apr 24, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪0.50‬
‪1.00‬
‪1.50‬
‪2.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange WEST PHARM.SVCS DL-,25 stocks are traded under the ticker WPS.
We've gathered analysts' opinions on WEST PHARM.SVCS DL-,25 future price: according to them, WPS price has a max estimate of 311.16 EUR and a min estimate of 229.78 EUR. Watch WPS chart and read a more detailed WEST PHARM.SVCS DL-,25 stock forecast: see what analysts think of WEST PHARM.SVCS DL-,25 and suggest that you do with its stocks.
WPS reached its all-time high on Jan 3, 2022 with the price of 420.20 EUR, and its all-time low was 12.10 EUR and was reached on Oct 5, 2010. View more price dynamics on WPS chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track WEST PHARM.SVCS DL-,25 financials in yearly and quarterly reports right on TradingView.
WEST PHARM.SVCS DL-,25 is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
WPS earnings for the last quarter are 1.76 EUR per share, whereas the estimation was 1.66 EUR resulting in a 5.87% surprise. The estimated earnings for the next quarter are 1.17 EUR per share. See more details about WEST PHARM.SVCS DL-,25 earnings.
WEST PHARM.SVCS DL-,25 revenue for the last quarter amounts to ‪723.32 M‬ EUR, despite the estimated figure of ‪715.28 M‬ EUR. In the next quarter, revenue is expected to reach ‪652.65 M‬ EUR.
WPS net income for the last quarter is ‪125.67 M‬ EUR, while the quarter before that showed ‪122.15 M‬ EUR of net income which accounts for 2.89% change. Track more WEST PHARM.SVCS DL-,25 financial stats to get the full picture.
Yes, WPS dividends are paid quarterly. The last dividend per share was 0.20 EUR. As of today, Dividend Yield (TTM)% is 0.38%. Tracking WEST PHARM.SVCS DL-,25 dividends might help you take more informed decisions.
WEST PHARM.SVCS DL-,25 dividend yield was 0.25% in 2024, and payout ratio reached 12.27%. The year before the numbers were 0.22% and 9.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 23, 2025, the company has ‪10.60 K‬ employees. See our rating of the largest employees — is WEST PHARM.SVCS DL-,25 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WEST PHARM.SVCS DL-,25 EBITDA is ‪726.03 M‬ EUR, and current EBITDA margin is 25.93%. See more stats in WEST PHARM.SVCS DL-,25 financial statements.
Like other stocks, WPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WEST PHARM.SVCS DL-,25 stock right from TradingView charts — choose your broker and connect to your account.